JANE STREET GROUP, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$2,696,000
+546.5%
112,810
+295.9%
0.00%
Q4 2020$417,000
-74.7%
28,491
-75.5%
0.00%
Q3 2020$1,651,000
+79.8%
116,242
+86.3%
0.00%
Q2 2020$918,000
+38.9%
62,400
+27.8%
0.00%
-100.0%
Q2 2014$661,00048,8240.01%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders